In the outpatient setting, during the 2023-24 flu season (October 2023-April 2024), only 31% of children and adolescents recommended to receive flu antiviral treatment (children younger than 5 or those with certain underlying conditions, who are considered to be at higher risk of developing serious flu complications) were prescribed antivirals.
Nirsevimab reduced the risk of respiratory syncytial virus (RSV)-associated hospitalization by 89% for American Indian/Alaska Native infants in Alaska’s Yukon-Kuskokwim Delta region in their first RSV season.
In April 2023, a public health emergency was declared in American Samoa after the American Samoa Department of Health received positive measles immunoglobulin (IgM) test results for two vaccinated children with rash illness.
Measles vaccination coverage during the COVID-19 pandemic declined to the lowest level (81%) since 2008. Coverage improved slightly during 2022–2023 (83%) but remained below pre-pandemic levels (86%).
New MMWR and Medscape CE on Seasonal Trends in Emergency Department Visits for Mental and Behavioral Health Conditions Among Children and Adolescents Aged 5–17 Years.
The latest MMWR Weekly Briefing is live. Topics include: flu and COVID-19 vaccination among U.S. health care workers, cases of sexually transmitted ringworm in the U.S., and more. Listen and subscribe on: Apple Podcasts and Spotify.
